No summary available
1
hour
hour
Expired
Searching for Solutions
No summary available
1
hour
hour
Expired
No summary available
1
hour
hour
Expired
No summary available
No summary available
1.25
hours
hours
Expired
No summary available
1.25
hours
hours
Expired
No summary available
No summary available
No summary available
1
hour
hour
Expired
No summary available
1
hour
hour
Expired
No summary available
1
hour
hour
Expired
No summary available
1
hour
hour
Expired
No summary available
1
hour
hour
Expired
No summary available
1.25
hours
hours
Expired
No summary available
1.25
hours
hours
Expired
No summary available
No summary available
1
hour
hour
Expired
No summary available
1
hour
hour
Expired
No summary available
1
hour
hour
Expired
What I Wish I Knew - Considerations for Creating a LGBTQIA+ Friendly Health Care Environment
Carolanne Wartman, PharmD, BCPS, BCPP (she/her) discussing asking, advocating, and creating inclusive environments for LGBTQIA+ patients.
Suicide is a global public health concern and a priority of the World Health Organization (WHO) since 2014. It has a devastating impact on communities and families. Psychiatric pharmacists implement evidence-based suicide risk mitigation interventions and are a key part of suicide prevention strategies.
Access to specialized mental health and crisis professionals for children and adolescents is severely limited contributing to the growing youth mental health crisis. This issue brief outlines how psychiatric pharmacists are part of the solution to achieve both early intervention and optimization of medications to improve outcomes.
Both methadone and buprenorphine are considered first-line medications for opioid use disorder (MOUD) with a demonstrated reduction in morbidity and mortality associated with opioid use disorder (OUD).
Substance use disorders (SUD) are a major public health crisis impacting families, communities and society.